Yahoo Web Search

Search results

    • Q1 2024 Cellectar Biosciences Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 43 minutes ago

      We are evaluating CLR 121225 in additional preclinical models, such as ovarian and triple negative breast cancer, and plan to initiate a Phase 1 study in one of these solid ...